eKuore's proposal is based on creating a system that allows for the early detection of idiopathic pulmonary fibrosis (IPF) and murmurs in pediatric cardiology, through an algorithm that recognizes auscultation obtained with the company's digital stethoscope. Rubén López, eKuore's CEO, states that "the purpose of the company with this round of investment is to accelerate the project to introduce a pre-diagnosis system into the market that will allow the doctor to be warned of a disease up to two years earlier than with current processes".
Read the full story at Valencia Plaza